Comparing Pericapsular Nerve Group Block With Lumbar Erector Spinae Plain Block in Total Hip Arthroplasty Surgery

Sponsor
Marmara University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06059339
Collaborator
(none)
66
1
22
3

Study Details

Study Description

Brief Summary

Total hip arthroplasty is a common surgical procedure aiming to improve mobility and quality of life in patients suffering from hip pain. Despite being a frequently performed procedure, there is high variability in the peri-operative anaesthetic and analgesic management for total hip arthroplasty.

Beyond the immediate postoperative period, regional anesthesia and analgesia can have potentially beneficial effects on long-term outcomes, especially on postoperative pain, functional rehabilitation and morbidity .

The primary implication of this study is to compare postoperative opioid consumption of patients' after total hip arthroplasty using pericapsular nerve group (PENG) block with lumbar erector spinae plain block.

Condition or Disease Intervention/Treatment Phase
  • Other: Procedure/Surgery: Regional Block Comparison Comparing postoperative pain and opioid consumption in groups

Detailed Description

Total hip arthroplasty is a common surgical procedure aiming to improve mobility and quality of life in patients suffering from hip pain. Despite being a frequently performed procedure, there is high variability in the peri-operative anaesthetic and analgesic management for total hip arthroplasty.

Beyond the immediate postoperative period, regional anesthesia and analgesia can have potentially beneficial effects on long-term outcomes, especially on postoperative pain, functional rehabilitation and morbidity .

The primary implication of this study is to compare postoperative opioid consumption of patients' after total hip arthroplasty using pericapsular nerve group (PENG) block with lumbar erector spinae plain block.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
66 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Comparing Postoperative Opioid Consumption of Pericapsular Nerve Group (PENG) Block With Lumbar Erector Spinae Plain Block in Total Hip Arthroplasty Surgery
Actual Study Start Date :
Jul 22, 2022
Anticipated Primary Completion Date :
Apr 22, 2024
Anticipated Study Completion Date :
May 22, 2024

Arms and Interventions

Arm Intervention/Treatment
PENG Block and Spinal Anesthesia

The patients receive PENG block for postoperative pain management at the beginning of the surgery. TheLESP block will be provided with 20 ml 0,025% bupivacain under ultrasonography.

Other: Procedure/Surgery: Regional Block Comparison Comparing postoperative pain and opioid consumption in groups
Procedure/Surgery: Regional Block Comparison Comparing postoperative pain and opioid consumption in groups

Lumbar Erector Spinae Plain Block and Spinal Anesthesia

The patients receive LESP block for postoperative pain management at the beginning of the surgery. TheLESP block will be provided with 20 ml 0,025% bupivacain under ultrasonography.

Other: Procedure/Surgery: Regional Block Comparison Comparing postoperative pain and opioid consumption in groups
Procedure/Surgery: Regional Block Comparison Comparing postoperative pain and opioid consumption in groups

PENG Block and Lumbar Erector Spinae Plain Block and Spinal Anesthesia

The patients receive LESP block and PENG block for postoperative pain management at the beginning of the surgery. The LESP block and PENG block will be provided with 20 ml 0,025% bupivacain each under ultrasonography.

Other: Procedure/Surgery: Regional Block Comparison Comparing postoperative pain and opioid consumption in groups
Procedure/Surgery: Regional Block Comparison Comparing postoperative pain and opioid consumption in groups

Outcome Measures

Primary Outcome Measures

  1. Postoperative Pain Scores [48 Hours]

    Comparing pain scores with Numeric Rating Scale (NRS)

  2. Opioid Consumption [48 Hours]

    Comparing opioid consumption via Patient Controlled Analgesia (PCA) device

Secondary Outcome Measures

  1. Patient Satisfaction [48 Hours]

    Patient Satisfaction score- 0 to 5: unsatisfied:0 satisfied:5

  2. Complications Related to Pain Management [48 Hours]

    Complications Related to Pain Management- nausea, vomiting, itching

  3. Time of Mobilization [7 Days]

    the time between the surgery to mobilization of the patient

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients over 18 years old, undergoing total hip arthroplasty surgery
Exclusion Criteria:
  • Patients with solid organ dysfunction, chronic opioid or corticosteroid use, bleeding diathesis, patients receiving inpatient medication, patients with psychiatric disorders and patients who cannot be contacted after surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Marmara University Istanbul Turkey

Sponsors and Collaborators

  • Marmara University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beliz Bilgili, Associate Professor, Marmara University
ClinicalTrials.gov Identifier:
NCT06059339
Other Study ID Numbers:
  • 01.2023.886
First Posted:
Sep 28, 2023
Last Update Posted:
Oct 3, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Beliz Bilgili, Associate Professor, Marmara University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 3, 2023